Published in J Am Acad Dermatol on July 01, 2003
The Influence of Peripheral Androgen Conversion at Women Adult Acne | NCT01850095
Split Face Comparative Study of Microneedling with PRP Versus Microneedling with Vitamin C in Treating Atrophic Post Acne Scars. J Cutan Aesthet Surg (2015) 1.45
Management of acne. CMAJ (2011) 1.09
Acne-specific quality of life questionnaire (Acne-QoL): translation, cultural adaptation and validation into Brazilian-Portuguese language. An Bras Dermatol (2014) 1.09
Retinoic acid as a vaccine adjuvant enhances CD8+ T cell response and mucosal protection from viral challenge. J Virol (2011) 1.08
The use of isotretinoin in acne. Dermatoendocrinol (2009) 1.06
A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. J Clin Aesthet Dermatol (2010) 1.02
The role of inflammation in the pathology of acne. J Clin Aesthet Dermatol (2013) 0.99
Analysis of complete genomes of Propionibacterium acnes reveals a novel plasmid and increased pseudogenes in an acne associated strain. Biomed Res Int (2013) 0.98
The epidemiology of acne vulgaris in late adolescence. Adolesc Health Med Ther (2016) 0.94
Comparative study of oral isotretinoin versus oral isotretinoin + 20% salicylic Acid peel in the treatment of active acne. J Cutan Aesthet Surg (2013) 0.91
The effect of evening primrose oil for the prevention of xerotic cheilitis in acne patients being treated with isotretinoin: a pilot study. Ann Dermatol (2014) 0.91
Acne: more than skin deep. Postgrad Med J (2006) 0.90
Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier? J Clin Aesthet Dermatol (2013) 0.90
Minocycline-Induced Cutaneous Hyperpigmentation in an Orthopedic Patient Population. Open Forum Infect Dis (2016) 0.89
Acne vulgaris treatment : the current scenario. Indian J Dermatol (2011) 0.89
The Role of Skin Care as an Integral Component in the Management of Acne Vulgaris: Part 2: Tolerability and Performance of a Designated Skin Care Regimen Using a Foam Wash and Moisturizer SPF 30 in Patients with Acne Vulgaris Undergoing Active Treatment. J Clin Aesthet Dermatol (2013) 0.87
Moisturizers for Acne: What are their Constituents? J Clin Aesthet Dermatol (2014) 0.87
Adapalene 0.3% for the treatment of acne in women. J Clin Aesthet Dermatol (2013) 0.85
In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes. J Clin Aesthet Dermatol (2011) 0.85
Taking the stress out of acne management. Can Fam Physician (2009) 0.83
Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled trial. Indian J Pharmacol (2011) 0.83
Management strategies for acne vulgaris. Clin Cosmet Investig Dermatol (2011) 0.82
The influence of selected ingredients of dietary supplements on skin condition. Postepy Dermatol Alergol (2014) 0.81
A New, Once-daily, Optimized, Fixed Combination of Clindamycin Phosphate 1.2% and Low-concentration Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-Severe Acne. J Clin Aesthet Dermatol (2009) 0.81
New perspectives on antiacne plant drugs: contribution to modern therapeutics. Biomed Res Int (2014) 0.80
Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris. J Clin Aesthet Dermatol (2015) 0.80
What is the Role of Benzoyl Peroxide Cleansers in Acne Management?: Do they Decrease Propionibacterium acnes Counts? Do they Reduce Acne Lesions? J Clin Aesthet Dermatol (2008) 0.80
Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives. J Clin Aesthet Dermatol (2011) 0.79
Congenital adrenal hyperplasia. Dermatoendocrinol (2009) 0.78
Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne. Int J Womens Health (2010) 0.78
Benzoyl Peroxide Microsphere Formulations: What is the Science Supporting Microsphere Vehicle Technology and Clinical Use? J Clin Aesthet Dermatol (2009) 0.78
Profiling and hormonal therapy for acne in women. Indian J Dermatol (2014) 0.78
Moisturizers and Ceramide-containing Moisturizers May Offer Concomitant Therapy with Benefits. J Clin Aesthet Dermatol (2014) 0.78
A small peptide with therapeutic potential for inflammatory acne vulgaris. PLoS One (2013) 0.77
Severe teenage acne and risk of endometriosis. Hum Reprod (2014) 0.77
Exploring Valrubicin's Effect on Propionibacterium Acnes-Induced Skin Inflammation in Vitro and in Vivo. Dermatol Reports (2015) 0.77
In vivo treatment of Propionibacterium acnes infection with liposomal lauric acids. Adv Healthc Mater (2013) 0.77
Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study. Am J Clin Dermatol (2016) 0.77
Acne vulgaris: prevalence and clinical forms in adolescents from São Paulo, Brazil. An Bras Dermatol (2014) 0.76
The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. J Clin Aesthet Dermatol (2009) 0.76
Intense pulsed light versus benzoyl peroxide 5% gel in treatment of acne vulgaris. Lasers Med Sci (2013) 0.76
Susceptibility of Propionibacterium acnes isolated from patients with acne vulgaris to zinc ascorbate and antibiotics. Clin Cosmet Investig Dermatol (2011) 0.76
Microsphere technology: hype or help? J Clin Aesthet Dermatol (2011) 0.76
Association of pharyngitis with oral antibiotic use for the treatment of acne: a cross-sectional and prospective cohort study. Arch Dermatol (2011) 0.76
Oral Doxycycline in the Management of Acne Vulgaris: Current Perspectives on Clinical Use and Recent Findings with a New Double-scored Small Tablet Formulation. J Clin Aesthet Dermatol (2015) 0.76
New developments in acne treatment: role of combination adapalene-benzoylperoxide. Ther Clin Risk Manag (2016) 0.75
Carrier-based drug delivery system for treatment of acne. ScientificWorldJournal (2014) 0.75
Management of Papulopustular Rosacea and Perioral Dermatitis with Emphasis on Iatrogenic Causation or Exacerbation of Inflammatory Facial Dermatoses: Use of Doxycycline-modified Release 40mg Capsule Once Daily in Combination with Properly Selected Skin Care as an Effective Therapeutic Approach. J Clin Aesthet Dermatol (2011) 0.75
Is less more with isotretinoin and acne? Can Fam Physician (2016) 0.75
The use of isotretinoin in the treatment of acne vulgaris: clinical considerations and future directions. J Clin Aesthet Dermatol (2014) 0.75
The blemishes of modern society? Acne prevalence in the Dogon of Mali. Evol Med Public Health (2016) 0.75
Inhibition of lipase and inflammatory mediators by Chlorella lipid extracts for antiacne treatment. J Adv Pharm Technol Res (2015) 0.75
A Three-Step Acne System Containing Solubilized Benzoyl Peroxide versus Benzoyl Peroxide/Clindamycin in Pediatric Patients with Acne. J Clin Aesthet Dermatol (2009) 0.75
Large-scale survey to describe acne management in Brazilian clinical practice. Clin Cosmet Investig Dermatol (2015) 0.75
Topical, Biological and Clinical Challenges in the Management of Patients with Acne Vulgaris. Sultan Qaboos Univ Med J (2016) 0.75
Acne scars in 18-year-old male adolescents: a population-based study of prevalence and associated factors. An Bras Dermatol (2016) 0.75
A Meta-analysis to Investigate the Relation Between Fitzpatrick Skin Types and Tolerability of Adapalene-Benzoyl Peroxide Topical Gel in Subjects with Mild or Moderate Acne. J Clin Aesthet Dermatol (2010) 0.75
Optimizing Non-Antibiotic Treatments for Patients with Acne: A Review. Dermatol Ther (Heidelb) (2016) 0.75
Survivin as a Novel Biomarker in the Pathogenesis of Acne Vulgaris and Its Correlation to Insulin-Like Growth Factor-I. Dis Markers (2016) 0.75
Adapalene-benzoyl Peroxide Gel is Efficacious and Safe in Adult Female Acne, with a Profile Comparable to that Seen in Teen-aged Females. J Clin Aesthet Dermatol (2016) 0.75
Face to face with oral isotretinoin: a closer look at the spectrum of therapeutic outcomes and why some patients need repeated courses. J Clin Aesthet Dermatol (2012) 0.75
An innovative approach to the topical treatment of acne. Clin Cosmet Investig Dermatol (2015) 0.75
Clindamycin Phosphate 1.2%/Tretinoin 0.025% Gel for the Treatment of Acne Vulgaris: Which Patients are Most Likely to Benefit the Most? J Clin Aesthet Dermatol (2015) 0.75
How People with Facial Acne Scars are Perceived in Society: an Online Survey. Dermatol Ther (Heidelb) (2016) 0.75
Evaluation of the Quantitative and Qualitative Alterations in the Fatty Acid Contents of the Sebum of Patients with Inflammatory Acne during Treatment with Systemic Lymecycline and/or Oral Fatty Acid Supplementation. Dermatol Res Pract (2013) 0.75
Results of a Multicenter, Randomized, Controlled Trial of a Hydrogen Peroxide-based Kit versus a Benzoyl Peroxide-based Kit in Mild-to-moderate Acne. J Clin Aesthet Dermatol (2016) 0.75
Fixed-Combination Gels of Adapalene and Benzoyl Peroxide Provide Optimal Percutaneous Absorption Compared to Monad Formulations of These Compounds: Results from Two In Vitro Studies. Dermatol Ther (Heidelb) (2016) 0.75
Antiandrogenic Therapy with Ciproterone Acetate in Female Patients Who Suffer from Both Androgenetic Alopecia and Acne Vulgaris. Clujul Med (2014) 0.75
The efficacy of oral isotretinoin versus cyproterone compound in female patients with acne and the triad of cutaneous hyperandrogenism: A randomized clinical trial. Adv Biomed Res (2014) 0.75
A review of the safety and efficacy of benzoyl peroxide (5.3%) emollient foam in the management of truncal acne vulgaris. J Clin Aesthet Dermatol (2010) 0.75
Non-antibiotic Isotretinoin Treatment Differentially Controls Propionibacterium acnes on Skin of Acne Patients. Front Microbiol (2017) 0.75
Oily Skin: A review of Treatment Options. J Clin Aesthet Dermatol (2017) 0.75
Effects of herbal medicine for dysmenorrhea treatment on accompanied acne vulgaris: a study protocol for a randomized controlled trial. BMC Complement Altern Med (2017) 0.75
Synchronizing Pharmacotherapy in Acne with Review of Clinical Care. Indian J Dermatol (2017) 0.75
Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med (2011) 45.46
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med (2015) 14.71
Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med (2012) 11.72
A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med (2002) 5.58
Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma. J Clin Oncol (2013) 5.36
Guidelines of care for acne vulgaris management. J Am Acad Dermatol (2007) 2.80
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study. J Clin Oncol (2004) 2.50
A single cycle of rituximab for the treatment of severe pemphigus. N Engl J Med (2007) 2.41
New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol (2009) 2.28
Safety of doxycycline and minocycline: a systematic review. Clin Ther (2005) 1.89
Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones. J Invest Dermatol (2009) 1.87
Defining early mycosis fungoides. J Am Acad Dermatol (2005) 1.78
Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma. J Clin Oncol (2013) 1.67
Brain magnetic resonance imaging in patients with Cowden syndrome. Medicine (Baltimore) (2005) 1.50
Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndrome. Arch Dermatol (2008) 1.47
Large-scale worldwide observational study of adherence with acne therapy. Int J Dermatol (2010) 1.43
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. J Invest Dermatol (2009) 1.26
Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. Acta Derm Venereol (2002) 1.19
Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol (2006) 1.17
Anti-inflammatory properties of narrow-band blue light. J Drugs Dermatol (2006) 1.16
Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response. Sci Transl Med (2013) 1.15
Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-A-specific T cells. J Immunol (2005) 1.13
Male axillary extracts contain pheromones that affect pulsatile secretion of luteinizing hormone and mood in women recipients. Biol Reprod (2003) 1.13
MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency. J Exp Med (2008) 1.13
Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study. Arch Dermatol (2006) 1.10
IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. J Invest Dermatol (2007) 1.10
Effective over-the-counter acne treatments. Semin Cutan Med Surg (2008) 1.08
Gluten intolerance and skin diseases. Eur J Dermatol (2006) 1.08
Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial. Arch Dermatol (2002) 1.07
New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol (2013) 1.06
Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol (2002) 1.05
Histone H4 is a major component of the antimicrobial action of human sebocytes. J Invest Dermatol (2009) 1.03
Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial. Contraception (2008) 1.01
Effect of antibiotics on the oropharyngeal flora in patients with acne. Arch Dermatol (2003) 0.99
Acne vulgaris, II: treatment. Cutis (2002) 0.99
Correlation between serum levels of insulin-like growth factor 1, dehydroepiandrosterone sulfate, and dihydrotestosterone and acne lesion counts in adult women. Arch Dermatol (2005) 0.98
Acne and systemic disease. Med Clin North Am (2009) 0.98
Can we define acne as a chronic disease? If so, how and when? Am J Clin Dermatol (2008) 0.98
Circulating tumor cells in melanoma patients. PLoS One (2012) 0.98
Hormonal therapy for acne. Semin Cutan Med Surg (2008) 0.97
Reduction in facial photodamage by a topical growth factor product. J Drugs Dermatol (2008) 0.96
Infantile acne: a retrospective study of 16 cases. Pediatr Dermatol (2008) 0.94
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients. Cancer Immunol Immunother (2006) 0.94
Standard management options for rosacea, part 2: options according to subtype. Cutis (2009) 0.94
Diet and acne. J Am Acad Dermatol (2010) 0.93
A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa. J Am Acad Dermatol (2009) 0.93
Body dysmorphic disorder symptoms among patients with acne vulgaris. J Am Acad Dermatol (2007) 0.92
In vitro modulation of TLR-2, CD1d and IL-10 by adapalene on normal human skin and acne inflammatory lesions. Exp Dermatol (2007) 0.92
Acne vulgaris, I: pathogenesis and diagnosis. Cutis (2002) 0.92
Changing the face of acne therapy. Cutis (2009) 0.92
The Dermatology Foundation: partnerships and programs focused on the future. J Invest Dermatol (2013) 0.92
Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin. J Drugs Dermatol (2012) 0.91
ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma. Pigment Cell Melanoma Res (2009) 0.91
alpha v beta3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen. J Exp Med (2005) 0.90
Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists. Cutis (2008) 0.90
Large-scale international study enhances understanding of an emerging acne population: adult females. J Eur Acad Dermatol Venereol (2014) 0.90
Interstitial brachytherapy of periorificial skin carcinomas of the face: a retrospective study of 97 cases. Int J Radiat Oncol Biol Phys (2005) 0.88
Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy. Eur J Immunol (2010) 0.88
Targeted melanoma prevention intervention: a cluster randomized controlled trial. Ann Fam Med (2014) 0.87
Genetic influences on human body odor: from genes to the axillae. J Invest Dermatol (2010) 0.87
Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant. J Drugs Dermatol (2011) 0.86
Melanomas Associated With Blue Nevi or Mimicking Cellular Blue Nevi: Clinical, Pathologic, and Molecular Study of 11 Cases Displaying a High Frequency of GNA11 Mutations, BAP1 Expression Loss, and a Predilection for the Scalp. Am J Surg Pathol (2016) 0.86
Large scale expansion of gamma 9 delta 2 T lymphocytes: Innacell gamma delta cell therapy product. J Immunol Methods (2007) 0.86
Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment. Clin Ther (2005) 0.86
The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. J Drugs Dermatol (2010) 0.86
Cosmeceuticals: practical applications. Dermatol Clin (2009) 0.86
Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: a multicenter, investigator-blind, randomized, controlled study. Skinmed (2005) 0.85
An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea. Cutis (2013) 0.85
In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes. J Clin Aesthet Dermatol (2011) 0.85
Understanding innate immunity and inflammation in acne: implications for management. J Eur Acad Dermatol Venereol (2015) 0.85
Emerging therapies in rosacea. J Am Acad Dermatol (2013) 0.85
Rituximab for primary cutaneous diffuse large B-cell lymphoma-leg type. Eur J Dermatol (2010) 0.84
Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial. Cutis (2002) 0.84
Body image disturbance in patients with acne vulgaris. J Clin Aesthet Dermatol (2011) 0.84
Botanicals and anti-inflammatories: natural ingredients for rosacea. Semin Cutan Med Surg (2011) 0.84
Large scale expansion of Vgamma9Vdelta2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS "TCR gamma/delta+ T cell isolation kit". J Immunol Methods (2009) 0.84
Tissue prognostic markers for adoptive immunotherapy in melanoma. Eur J Dermatol (2007) 0.84
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 5: a guide on the management of rosacea. Cutis (2014) 0.83
Melanoma incidence and patient compliance in a targeted melanoma screening intervention. One-year follow-up in a large French cohort of high-risk patients. Eur J Gen Pract (2014) 0.83
Standard management options for rosacea, part 1: overview and broad spectrum of care. Cutis (2009) 0.83
Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients. Cancer Immunol Immunother (2015) 0.83
Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials. Clin Ther (2004) 0.83
Consensus recommendations from the American Acne & Rosacea Society on the management of rosacea, part 2: a status report on topical agents. Cutis (2013) 0.83
Current concepts in the treatment of acne: report from a clinical roundtable. Cutis (2003) 0.83